Cheyenne Vissari
Nurse Practitioner · du Bois, PANPI 1720855315
Payments from drug & device makers
Across 17 payments — averaging $27.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$90
- Boston Scientific$77
- Ferring Pharmaceuticals Inc.$33
- Johnson & Johnson$26
- Genentech USA, Inc.$25
- Lilly USA, LLC$25
- plus $187 from 10 others
What the payments were for
- Food & beverage$463100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 1 | $90 |
| Boston Scientific | 1 | $77 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Johnson & Johnson | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| Springworks Therapeutics, Inc. | 1 | $24 |
| Acrotech Biopharma Inc. | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Cumberland Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Novartis | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Urogen Pharma, Inc. | 1 | $15 |
| GSK | 1 | $14 |
How this compares
$463 in reported general payments places this provider in the 70th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 39 | $269 |
| Doxycycline Hyclate | 11 | $253 |
| Omeprazole | 27 | $219 |
| Atorvastatin Calcium | 30 | $215 |
| Rosuvastatin Calcium | 12 | $194 |
| Amlodipine Besylate | 33 | $177 |
| Pravastatin Sodium | 13 | $152 |
| Methylprednisolone | 16 | $104 |
| Fluticasone Propionate | 13 | $103 |
| Losartan Potassium | 13 | $90 |
| Lisinopril | 25 | $64 |
| Azithromycin | 15 | $41 |
| Hydrochlorothiazide | 13 | $31 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in du Bois
- Jean Levindu Bois$15K
- Todd Sudikdu Bois$11K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.